Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name over-the-counter medicine

Pataday Once Daily

Generic name: Olopatadine

FDA application holder: Alcon Labs Inc

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Read the label on your package, and ask a pharmacist if you are not sure a medicine is right for you or your child.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Pataday Once Daily?
Pataday Once Daily is a brand name of Olopatadine, an over-the-counter medicine. The FDA NDC Directory lists 3 Pataday Once Daily products in 3 strengths and forms.
Who makes Pataday Once Daily?
Alcon Labs Inc holds the FDA application for Pataday Once Daily (NDA020688, approved December 18, 1996).
Is there a generic or store brand of Pataday Once Daily?
Yes. The FDA NDC Directory lists 72 other products with the same active ingredients, strength and form as a Pataday Once Daily product, 72 of them generic or store brands. Ask your pharmacist whether one is right for you.
What do pharmacies pay for Pataday Once Daily?
CMS lists a National Average Drug Acquisition Cost (NADAC) for 3 Pataday Once Daily strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
Has Pataday Once Daily been recalled?
FDA enforcement reports list 1 recall of Pataday Once Daily products; the newest started June 29, 2022. A recall usually concerns specific lots, not every product.

What Pataday Once Daily is

Each Pataday Once Daily product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Olopatadine · over-the-counter medicine

Strength and formProduct namesSame medicine, other namesLabel
olopatadine hydrochloride 1 mg/mL
solution (ophthalmic)
Pataday Twice a Day Relief 24 products, 21 companies DailyMed
olopatadine hydrochloride 2 mg/mL
solution (ophthalmic)
Pataday Once Daily Relief 43 products, 32 companies DailyMed
olopatadine hydrochloride 7 mg/mL
solution (ophthalmic)
Pataday Once Daily Relief 5 products, 4 companies DailyMed

Its page quotes the Drug Facts label and lists every brand and store brand: Olopatadine →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Pataday Once Daily products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA020688Alcon Labs IncDecember 18, 19961
NDA021545Alcon Labs IncDecember 22, 20041
NDA206276Alcon Labs IncJanuary 30, 20151

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Pataday Once Daily, by strength and form
Strength and formGeneric or brandPharmacies pay
olopatadine hydrochloride 1 mg/mL
solution
Brand: Pataday Once Daily $2.48 per mL
Generic of the same strength and form: $1.24 per mL
olopatadine hydrochloride 2 mg/mL
solution
Brand: Pataday Once Daily $5.94 per mL
Generic of the same strength and form: $2.03–$2.98 per mL
olopatadine hydrochloride 7 mg/mL
solution
Brand: Pataday Once Daily $6.21 per mL

NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list Pataday Once Daily

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Pataday Once Daily products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. June 29, 2022 · Class II · Terminated · D-1321-2022

    CGMP Deviations: products were stored outside the drug label specifications.

    Pataday, Once Daily Relief, Olopatadine hydrochloride ophthalmic solution 0.2%, Antihistamine, Eye Allergy Itch Relief, Once Daily, Sterile, 2.5 mL (0.085 FL OZ) bottle per box, Alcon, NDC 0065-8150-01. — Mckesson Medical-Surgical Inc. Corporate Office

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers